text
stringlengths 0
146
|
|---|
specialist.
|
Carcinoma in situ of
|
Specified Organs treated
|
with Radical Surgery
|
The actual undergoing of a
|
Radical Surgery to arrest
|
the
|
spread of malignancy in
|
that specific organ, which
|
must be considered as
|
appropriate and necessary
|
treatment.
|
“Radical Surgery” is
|
defined in this policy as
|
the total and complete
|
removal of one (1) of the
|
following organs: breast
|
(mastectomy), prostate
|
(prostatectomy), corpus
|
uteri (hysterectomy), ovary
|
(oopherectomy), fallopian
|
tube (salpingectomy),
|
colon (partial colectomy
|
with end to end
|
anastomosis) or stomach
|
(partial gastrectomy with
|
end to end anastomosis).
|
The diagnosis of the
|
Carcinoma in situ must
|
always be positively
|
Major Burns
|
Third degree (full
|
thickness of the skin)
|
burns covering at least
|
20% of the surface of the
|
life insured’s body.
|
Major Cancer
|
A malignant tumour
|
positively diagnosed with
|
histological confirmation
|
and characterized by the
|
uncontrolled growth of
|
malignant cells with
|
invasion and destruction of
|
normal tissue.
|
The term Major Cancer
|
includes, but is not limited
|
to, leukemia, lymphoma
|
and sarcoma.
|
Major Cancer diagnosed
|
on the basis of finding
|
tumour cells and/or
|
tumour-associated
|
molecules in blood, saliva,
|
faeces, urine or any other
|
bodily fluid in the absence
|
of further definitive and
|
clinically verifiable
|
evidence does not meet
|
the above definition.
|
For the above definition,
|
the following are excluded:
|
Manulife CI FlexiCare (Deluxe) v0123
|
Page 22 of 42
|
Manulife (Singapore) Pte. Ltd.
|
A Manulife Company
|
Conditions
|
Early Stage
|
Prostate cancer that is
|
histologically described
|
using the TNM
|
Classification as T1N0M0
|
or Prostate cancers
|
described using another
|
equivalent classification.
|
Early Thyroid Cancer
|
Thyroid cancer that is
|
histologically described
|
using the TNM
|
Classification as T1N0M0
|
as well as Papillary
|
microcarcinoma of thyroid.
|
Early Bladder Cancer
|
Bladder cancer that is
|
histologically described
|
using the TNM
|
Classification as Tis or
|
T1N0M0. Non-invasive
|
papillary urothelial
|
carcinoma of the bladder
|
(stage Ta) is excluded.
|
Early Chronic
|
Lymphocytic Leukemia
|
Chronic Lymphocytic
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.